Correspondence 0001104659-24-004680 from Accelerate Diagnostics, Inc (AXDX) (CIK 0000727207)
Accelerate Diagnostics, Inc (AXDX) (CIK 0000727207)
Date: Jan. 18, 2024 · CIK: 0000727207 · Accession: 0001104659-24-004680
AI Filing Summary & Sentiment
File numbers found in text: 333-276031
Letter
Re: Accelerate Diagnostics, Inc.
January 18, 2024
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attn: Katherine Bagley
Registration Statement on Form S-1
File No. 333-276031
Acceleration Request
Requested Date:
January 18, 2024
Requested Time:
4:00 P.M., Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Accelerate Diagnostics, Inc. (the “Company”), hereby requests that the effective date of the Company’s Registration Statement on Form S-1, Registration Number 333-276031 (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:00 P.M. Eastern Time, on January 18, 2024 or as soon thereafter as practicable or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission.
We would appreciated it if, as soon as the Registration Statement is declared effective, you would so inform Istvan A. Hajdu of Sidley Austin LLP at (212) 839-5651.
Very truly yours,
/s/ David Patience
Show Raw Text
CORRESP
1
filename1.htm
January 18, 2024
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attn: Katherine Bagley
Re:
Accelerate Diagnostics, Inc.
Registration Statement on Form S-1
File No. 333-276031
Acceleration Request
Requested Date:
January 18, 2024
Requested Time:
4:00 P.M., Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461
under the Securities Act of 1933, as amended, Accelerate Diagnostics, Inc. (the “Company”), hereby requests
that the effective date of the Company’s Registration Statement on Form S-1, Registration Number 333-276031 (the “Registration
Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:00 P.M. Eastern
Time, on January 18, 2024 or as soon thereafter as practicable or at such later time as the Company or its counsel may orally request
via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission.
We would appreciated it if, as soon as the
Registration Statement is declared effective, you would so inform Istvan A. Hajdu of Sidley Austin LLP at (212) 839-5651.
Very truly yours,
/s/ David Patience
David Patience
Chief Financial Officer
Accelerate Diagnostics, Inc.
cc:
Jack Phillips, Chief Executive Officer
Michael A. Gordon, Sidley Austin LLP
Istvan A. Hajdu, Sidley Austin LLP
J. Carlton Fleming, Sidley Austin LLP
Michael D. Maline, Covington & Burling LLP
Brian K. Rosenzweig, Covington & Burling LLP
Keunjung Cho, Covington & Burling LLP